Regulatory Q&A Forum

When a medical device sponsor seeks 510(k) clearance for a new device that has the same intended use as a predicate device but incorporates different technological characteristics, how can they effect...

While the FDA's performance goal for reviewing a 510(k) submission is widely cited as 90 days, what factors contribute to the 'total elapsed time' from submission to a final decision often being longe...

What are the most common administrative reasons for an FDA 510(k) submission to receive a 'Refuse to Accept' (RTA) decision, and what proactive steps can sponsors take to ensure their submission packa...

When a medical device sponsor identifies the most suitable predicate for their 510(k) submission, but that predicate was cleared decades ago, how can they effectively demonstrate substantial equivalen...

I am working on preparing a 510(k) submission and want to understand how AI can help automate the creation and management of compliance checklists. What are the best practices, key capabilities, and i...

When a medical device sponsor receives a multi-point Additional Information (AI) request from the FDA during a 510(k) review, it initiates a critical phase governed by a 180-day response deadline. How...

With the FDA's electronic Submission Template And Resource (eSTAR) now mandatory for 510(k) submissions, sponsors must navigate the specific technical requirements of this dynamic PDF to avoid adminis...

For a small medical device company or startup, managing cash flow is critical. The Medical Device User Fee Amendments (MDUFA) user fees required for premarket submissions like a 510(k) can represent a...

Medical device sponsors preparing a 510(k) submission must account for the Medical Device User Fee Amendments (MDUFA) user fee, which is required before the FDA will accept the submission for review. ...

When a sponsor develops a novel, low-to-moderate risk medical device, such as an AI-powered diagnostic tool, they often face a critical strategic decision if no clear predicate device exists. The two ...

In the context of the 510(k) program, how should a manufacturer approach a 'split predicate' strategy when no single device can serve as a primary predicate? This situation often arises for devices th...

When preparing a 510(k) submission, a sponsor often identifies multiple potential predicate devices, each with its own advantages and disadvantages. Consider a scenario involving a new Class II diagno...

For small medical device companies and startups, budgeting for a 510(k) submission involves more than just development and testing costs; FDA user fees under the Medical Device User Fee Amendments (MD...

When a manufacturer plans to modify a 510(k)-cleared medical device—for example, by changing a component supplier for an infusion pump or updating the software algorithm in a diagnostic imaging system...

For a sponsor developing a connected Software as a Medical Device (SaMD), such as an AI-powered diagnostic tool, what are the key elements of a comprehensive cybersecurity documentation package for a ...

For a new Class II medical device seeking clearance via the 510(k) pathway, a critical strategic decision involves defining the scope of performance testing required to demonstrate substantial equival...

When a manufacturer of a 510(k)-cleared device, such as a cardiovascular catheter, plans to implement post-market changes, a critical regulatory assessment is required. These modifications can range f...

When preparing a 510(k) submission, the choice of a predicate device is a foundational strategic decision. Sponsors may face a scenario where no single legally marketed device is a perfect match. For ...

Our team is preparing a 510(k) submission for a new patient monitoring device, and we’ve just learned that our chosen primary predicate has been subject to a Class II recall due to a specific design f...